Seronegative Myasthenia Gravis - Efgartigimod IV

NCT06587867 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Health Network, Toronto